No increase in mortality and morbidity among carriers of the C282Y mutation of the hereditary haemochromatosis gene in the oldest old: The Leiden 85-plus Study

European Journal of Clinical Investigation

Volumn 32, Issue 10, 2002, Pages 750-754

  Van Aken, M O ^a   De Craen, A J M ^a   Gussekloo, J ^a   Moghaddam, P Hanifi ^a   Vandenbroucke, J P ^a   Heijmans, B T ^a   Slagboom, P E ^a   Westendorp, R G J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Elderly; Genetics; Haemochromatosis; Single nucleotide polymorphism

Indexed keywords

FERRITIN;

AGED; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GENE MUTATION; GROUPS BY AGE; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IRON METABOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SURVIVAL;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; FERRITINS; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; MALE; MEMBRANE PROTEINS; MORBIDITY; MUTATION; PENETRANCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 0036428690     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.01062.x     Document Type: Article

References (21)

1. Bacon BR. Haemochromatosis: Diagnosis and management. Gastroenterology 2001;120:718-25.
2. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
3. Steinberg KK, Cogswell ME, Chang JC, Caudill SP, McQuillan GM, Bowman BA et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA 2001;285:2216-22.
4. Hanson EH, Imperatore G, Burke W. HFE gene and heriditary hemochromatosis: A HuGE review. Human Genome Epidemiology. Am J Epidemiol 2001;154:193-206.
5. Adams PC. Nonexpressing homozygotes for C282Y hemochromatosis: Minority or majority of cases? Mol Genet Metab 2000;71:81-6.
6. Tuomainen T-P, Kontula K, Nyyssonen K, Kakka TA, Helio T, Salone JT. Increased risk of acute myocardial infarction in carriers of the haemochromatosis gene Cys282 Tyr mutation: A prospective cohort study in men in eastern Finland. Circulation 1999;100:1274-9.
7. Rasmussen ML, Folsom AR, Catellier DJ, Tsai MY, Garg U, Eckfeldt JH. A prospective study of coronary heart disease and the haemochromatosis gene (HFE) C282Y mutation: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2001;154:739-46.
8. Roest M, van der Schouw YT, de Valk B, Marx JJ, Tempelman MJ, de Groot PG et al. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 1999;100:1268-73.
9. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845GGA (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-8.
10. Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD et al. HFE mutations, iron deficiency and overload in 10 500 blood donors. Br J Haematol 2001;114:474-84.
11. Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, Larsen LE, Appleyard M, Frandson M et al. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: A retrospective study. Lancet 2001 October 27;358 (9291):1405-9.
12. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996;335:1799-805.
13. Nassar BA, Zayed EM, Title LM, O'Neill BJ, Bata IR, Kirkland SA et al. Relation of HFE gene mutations, high iron stores and early onset coronary artery disease. Can J Cardiol 1998;14:215-20.
14. Franco RF, Zago MA, Trip MD, ten Cate H, van den Ende A, Prins MH et al. Prevalence of hereditary hemochromatosis in premature atherosclerotic vascular disease. Br J Haematol 1998;102:1172-5.
15. Battiloro E, Ombres D, Pascale E, D'Ambrosio E, Verna R, Area M. Hemochromatosis gene mutations and risk of coronary heart disease. Eur J Hum Genet 2000;8:89-92.
16. Heijmans BT, Westendorp RGJ, Knook DL, Kluft C, Slagboom PE. Angiotensin I-converting enzyme and plasminogen activator inhibitor-1 gene variants. Risk of mortality and fatal cardiovascular disease in an elderly population-based cohort. J Am Coll Cardiol 1999;34:1176-83.
17. Lagaay AM, van der Meij JC, Hijmans W. Validation of medical history taking as part of a population based survey in subjects aged 85 and over. BMJ 1992;304:1091-2.
18. van Exel E, Gussekloo J, de Craen AJ, Bootsma-van der Wiel A, Houx P, Knook DL et al. Cognitive function in the oldest old: Women perform better than men. J Neurol Neurosurg Psychiatry 2001;71:29-32.
19. Willis G, Wimperis JZ, Smith KC, Fellows IW, Jennings BA. Haemochromatosis gene C282Y homozygotes in an elderly male population. Lancet 1999;354:221-2.
20. Lio D, Balistreri CR, Colonna-Romano G, Motta M, Franceschi C, Malaguarnera M, Candore G et al. Association between the MHC class I gene HFE polymorphisms and longevity: A study in Sicilian population. Genes Immun 2002;3:20-4.
21. Bathum L, Christiansen L, Nybo H, Ranberg KA, Gaist D, Jeune B et al. Association of mutations in the hemochromatosis gene with shorter life expectancy. Arch Intern Med 2001;161:2441-4.